Methyl (3S)-3-hydroxytetradecanoate, a compound readily available from NINGBO INNO PHARMCHEM CO.,LTD., is characterized by a unique set of physical and chemical properties that make it indispensable in specialized chemical synthesis, particularly within the pharmaceutical sector. As a leading pharmaceutical intermediate supplier in China, NINGBO INNO PHARMCHEM CO.,LTD. provides this compound with a consistent assay of ≥98.0%, underscoring its commitment to quality.

The compound's appearance as a white to off-white crystalline powder, coupled with a relatively low melting point of 43-45°C, facilitates its handling and processing in various chemical reactions. The molecular formula C15H30O3 and a molecular weight of 258.39700 provide specific parameters for its use in complex synthetic pathways. However, its most critical characteristic is its specific (3S) stereochemistry. This precise chirality is what makes Methyl (3S)-3-hydroxytetradecanoate an essential intermediate for the synthesis of Orlistat, a drug designed to inhibit fat absorption and aid in weight management. The successful production of Orlistat is directly dependent on the stereospecificity of this precursor.

NINGBO INNO PHARMCHEM CO.,LTD. offers this vital Orlistat synthesis chemical with the assurance of quality and reliability. The company's expertise in chemical manufacturing ensures that clients can buy Methyl (3S)-3-hydroxytetradecanoate knowing they are procuring a compound that meets stringent industry standards. Proper storage, typically in a cool and ventilated place, is recommended to maintain its integrity, a detail that NINGBO INNO PHARMCHEM CO.,LTD. emphasizes to its clients.

Beyond its primary application in Orlistat production, the inherent chemical structure of Methyl (3S)-3-hydroxytetradecanoate, with its hydroxyl and ester functional groups, presents potential for broader applications in fine chemical manufacturing and drug discovery. NINGBO INNO PHARMCHEM CO.,LTD., as a forward-thinking chemical manufacturer in China, is well-positioned to support these explorations, providing high-quality intermediates that drive innovation in the pharmaceutical and chemical industries.